Key terms
About BSGM
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BSGM news
Yesterday
8:42am ET
BioSig Technologies Announces Key Leadership Appointment
May 02
2:32pm ET
BioSig Technologies Strengthens Board with Industry Veteran
Apr 30
2:05pm ET
BioSig Technologies appoints Anthony Amato as CEO
Feb 28
9:12am ET
BioSig Technologies Announces Executive Leadership Changes
Feb 21
4:34pm ET
BioSig Technologies Inc Faces Wave of Executive Resignations
Feb 20
10:01am ET
BioSig Technologies terminates ‘significant number of its employees’
Feb 07
4:17am ET
BioSig Technologies Marks 100 Cases with Tracking Algorithm
Feb 06
8:40am ET
BioSig Technologies’ PURE EP platform surpasses 100 patient cases
No recent press releases are available for BSGM
BSGM Financials
Key terms
Ad Feedback
BSGM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BSGM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range